Viridian Therapeutics Q2 2019 Earnings Report

Total Revenue
$2.51M
Previous year: $2.18M
+15.2%
EPS
-$0.29
Previous year: -$0.29
+0.0%

Viridian Therapeutics

Viridian Therapeutics